HIV testing technologies range from rapid diagnostic tests and other technologies that enable testing at the point-of-care or near point-of care, to those that are used exclusively in high-level facilities and laboratories. Although most technologies for HIV testing have high sensitivity and specificity and are highly accurate when used in a validated national algorithm, the volume of tests conducted (over 150 million tests in 2014 alone), could result in thousands of misdiagnosed cases, particularly if not conducted correctly.
Continue reading “JIAS Call for Papers: Misdiagnosis of HIV Infection”
This report provides insight to the progress and impact of the global public health response to HIV for the past fifteen years. IeDEA regions analyzed existing data from regional cohorts of people living with HIV at various phases in the continuum of care from diagnosis to viral suppression including retention in care and delays in diagnosis. In addition, the Southern Africa Region of IeDEA provided data on estimates of life expectancy of adults on antiretroviral treatment for cohorts in Southern Africa.